Next-Generation Sequencing (NGS) Information & Technology Market Size, Share, Growth, and Industry Analysis, Types (Targeted, RNA-Seq, Exome), Applications (Diagnostics, Oncology, Drug Discovery, Agriculture), and Regional Insights and Forecast to 2035

Next-Generation Sequencing (NGS) Information & Technology Market Size

Global Next-Generation Sequencing (NGS) Information & Technology Market size was USD 7.36 Billion in 2025 and reached USD 8.80 Billion in 2026. It is projected to grow to USD 10.52 Billion in 2027 and expand to USD 44.09 Billion by 2035, exhibiting a CAGR of 19.61% during the forecast period. Around 68% of growth is driven by healthcare demand, while 60% comes from research and biotech applications.

The US Next-Generation Sequencing (NGS) Information & Technology Market shows strong growth, contributing nearly 36% of the regional share. Around 63% of healthcare providers use sequencing technologies for diagnostics. Nearly 58% of biotech companies rely on genomic data for innovation, supporting continued expansion in the country.

Key Findings

• Market Size: Valued at $7.36Bn in 2025, projected to touch $8.80Bn in 2026 to $44.09Bn by 2035 at a CAGR of 19.61%.
• Growth Drivers: 68% healthcare demand, 62% genomic adoption, 58% biotech usage, 55% diagnostics expansion, 50% research growth.
• Trends: 65% AI integration, 60% automation use, 56% cloud adoption, 52% faster sequencing, 48% improved data tools.
• Key Players: Illumina, BGI, Qiagen, Eurofins Scientific, Perkinelmer.
• Regional Insights: North America 38%, Europe 27%, Asia-Pacific 26%, Middle East & Africa 9% driven by healthcare and research demand.
• Challenges: 55% data privacy concerns, 50% compliance issues, 48% skill gaps, 45% storage limits, 42% cost barriers.
• Industry Impact: 67% improved diagnostics, 62% faster research, 58% better outcomes, 53% efficiency gains, 49% innovation growth.
• Recent Developments: 30% capacity expansion, 25% output growth, 22% productivity rise, 20% accuracy improvement, 18% faster analysis.

The Next-Generation Sequencing (NGS) Information & Technology Market continues to grow as healthcare systems adopt advanced technologies. Around 64% of demand is linked to diagnostics, while 57% comes from research activities. Nearly 52% of organizations are investing in innovation to improve performance and data management.

Next-Generation Sequencing (NGS) Information & Technology Market is shaping the future of healthcare by enabling faster and more accurate genetic analysis. Around 61% of applications focus on precision medicine, while 54% support drug discovery and research advancements across industries.

Next-Generation Sequencing (NGS) Information & Technology Market Trends

The Next-Generation Sequencing (NGS) Information & Technology Market is growing fast as healthcare, research, and biotech sectors rely more on genetic data. Around 68% of labs now use NGS tools for advanced analysis, while nearly 61% of hospitals are adopting sequencing-based diagnostics. Close to 57% of researchers prefer NGS due to its accuracy and speed compared to traditional methods. About 54% of pharmaceutical companies are using sequencing data in drug development pipelines. Nearly 49% of genetic testing services are now powered by NGS platforms. Around 46% of users report improved data processing through integrated IT systems. At the same time, about 52% of healthcare providers are focusing on personalized medicine supported by sequencing insights. The Next-Generation Sequencing (NGS) Information & Technology Market continues to expand as data-driven healthcare becomes more common.

Next-Generation Sequencing (NGS) Information & Technology Market Dynamics

OPPORTUNITY

Expansion of precision medicine

About 62% of healthcare systems are shifting toward precision medicine, creating strong demand for sequencing data. Nearly 58% of clinical trials now include genomic analysis. Around 55% of diagnostic labs are investing in NGS IT platforms to improve patient outcomes. This creates strong growth potential across healthcare systems.

DRIVERS

Rising demand for genomic data

Nearly 65% of research institutions rely on genomic datasets for innovation. About 60% of biotech firms use sequencing tools in R&D. Around 56% of healthcare providers are integrating NGS into diagnostics. This strong demand for data continues to push the Next-Generation Sequencing (NGS) Information & Technology Market forward.

RESTRAINTS

"High complexity in data interpretation"

Around 52% of users face challenges in analyzing sequencing data due to complexity. Nearly 48% of labs report a shortage of skilled professionals. About 45% of organizations struggle with data storage and processing limitations. These factors slow down adoption, especially in smaller healthcare setups.

CHALLENGE

"Data privacy and security concerns"

Nearly 55% of organizations highlight concerns around genetic data privacy. About 50% of healthcare providers face compliance challenges. Around 47% of institutions invest heavily in cybersecurity for NGS systems. These issues create barriers in wider adoption across regions.

Segmentation Analysis

The Next-Generation Sequencing (NGS) Information & Technology Market is segmented based on type and application, showing strong demand across healthcare, research, and agriculture. The market size was USD 7.36 Billion in 2025, reaching USD 8.80 Billion in 2026 and USD 10.52 Billion in 2027, and is projected to grow to USD 44.09 Billion by 2035, with a CAGR of 19.61%. Growth is supported by increasing use of genomic data and digital health tools.

By Type

Targeted Sequencing

Targeted sequencing holds around 38% share due to its efficiency in analyzing specific genes. Nearly 60% of clinical labs prefer this method for diagnostics. About 55% of applications focus on disease-specific testing, making it a key segment in the Next-Generation Sequencing (NGS) Information & Technology Market.

Targeted Sequencing Market Size was USD 3.34 Billion in 2026, representing 38% share, and is expected to grow at a CAGR of 19.61% from 2026 to 2035.

RNA-Seq

RNA-Seq accounts for nearly 34% share due to its role in gene expression studies. Around 58% of research labs use RNA sequencing for advanced biological insights. About 52% of pharmaceutical companies rely on this method for drug discovery and development processes.

RNA-Seq Market Size was USD 2.99 Billion in 2026, representing 34% share, and is expected to grow at a CAGR of 19.61% from 2026 to 2035.

Exome Sequencing

Exome sequencing holds about 28% share and is widely used for genetic disorder analysis. Nearly 54% of genetic testing labs adopt exome sequencing. Around 50% of healthcare providers use it for rare disease detection, making it an important segment in the market.

Exome Sequencing Market Size was USD 2.47 Billion in 2026, representing 28% share, and is expected to grow at a CAGR of 19.61% from 2026 to 2035.

By Application

Diagnostics

Diagnostics dominate with around 36% share as sequencing becomes a key part of clinical testing. Nearly 62% of hospitals use NGS for disease detection. About 57% of labs focus on genetic diagnostics, driving strong demand in this segment.

Diagnostics Market Size was USD 3.17 Billion in 2026, representing 36% share, and is expected to grow at a CAGR of 19.61% from 2026 to 2035.

Oncology

Oncology accounts for nearly 30% share, supported by rising cancer research. Around 59% of cancer studies use NGS data. About 55% of precision oncology treatments depend on sequencing insights, making it a major application area.

Oncology Market Size was USD 2.64 Billion in 2026, representing 30% share, and is expected to grow at a CAGR of 19.61% from 2026 to 2035.

Drug Discovery

Drug discovery holds about 20% share, with nearly 58% of pharma companies using NGS for research. Around 53% of new drug pipelines include genomic analysis. This segment continues to grow as biotechnology advances.

Drug Discovery Market Size was USD 1.76 Billion in 2026, representing 20% share, and is expected to grow at a CAGR of 19.61% from 2026 to 2035.

Agriculture

Agriculture represents around 14% share, driven by crop improvement programs. Nearly 51% of agricultural biotech firms use sequencing for research. About 47% of studies focus on improving crop yield and resistance using genomic tools.

Agriculture Market Size was USD 1.23 Billion in 2026, representing 14% share, and is expected to grow at a CAGR of 19.61% from 2026 to 2035.

Next-Generation Sequencing (NGS) Information & Technology Market Regional Outlook

The Global Next-Generation Sequencing (NGS) Information & Technology Market was valued at USD 7.36 Billion in 2025 and reached USD 8.80 Billion in 2026. It is expected to grow further to USD 10.52 Billion in 2027 and expand significantly to USD 44.09 Billion by 2035, showing a strong CAGR of 19.61% during the forecast period. Growth is driven by increasing adoption of genomic data, rising demand for precision medicine, and rapid expansion of bioinformatics solutions across healthcare and research sectors.

North America

North America holds the largest share of around 38% in the Next-Generation Sequencing (NGS) Information & Technology Market. Nearly 66% of healthcare institutions in this region use sequencing technologies for diagnostics and research. About 61% of pharmaceutical companies rely on genomic data for drug development. Strong infrastructure and advanced IT systems support adoption across labs and hospitals.

North America Market Size was USD 3.34 Billion in 2026, representing 38% of the total market. Growth is supported by high adoption of precision medicine, increasing clinical applications, and strong investment in genomic research and technology integration.

Europe

Europe accounts for approximately 27% of the Next-Generation Sequencing (NGS) Information & Technology Market. Around 60% of research labs actively use sequencing technologies for clinical and academic purposes. Nearly 56% of healthcare systems are integrating genomic data into patient care. The region shows steady demand driven by innovation and regulatory support.

Europe Market Size was USD 2.38 Billion in 2026, representing 27% of the total market. Demand is driven by growing healthcare digitization, research funding, and increased focus on personalized medicine solutions.

Asia-Pacific

Asia-Pacific holds around 26% share in the Next-Generation Sequencing (NGS) Information & Technology Market. Nearly 64% of growth comes from expanding healthcare infrastructure and research initiatives. About 59% of biotechnology companies in the region are adopting sequencing tools. Rapid development and population growth are boosting demand.

Asia-Pacific Market Size was USD 2.29 Billion in 2026, representing 26% of the total market. Growth is supported by increasing investments in healthcare, rising genetic research, and expanding biotech industries across emerging economies.

Middle East & Africa

Middle East & Africa represent around 9% of the Next-Generation Sequencing (NGS) Information & Technology Market. Nearly 52% of adoption is linked to healthcare modernization initiatives. About 48% of research institutions are exploring genomic technologies. The region is gradually expanding its use of sequencing tools in clinical and research settings.

Middle East & Africa Market Size was USD 0.79 Billion in 2026, representing 9% of the total market. Growth is supported by improving healthcare infrastructure, rising awareness, and gradual adoption of advanced genomic technologies.

List of Key Next-Generation Sequencing (NGS) Information & Technology Market Companies Profiled

Investment Analysis and Opportunities in Next-Generation Sequencing (NGS) Information & Technology Market

Investment in the Next-Generation Sequencing (NGS) Information & Technology Market is increasing rapidly due to growing demand for genomic insights. Around 67% of investors are focusing on healthcare and biotechnology sectors. Nearly 62% of funding is directed toward data analytics and bioinformatics platforms. About 58% of organizations are investing in advanced sequencing technologies to improve efficiency. Around 54% of companies are expanding infrastructure to handle large genomic datasets. Nearly 50% of stakeholders are targeting emerging markets for growth opportunities. In addition, about 47% of investments are focused on cloud-based solutions for data storage and analysis. These trends highlight strong opportunities for innovation and expansion in this market.

New Products Development

New product development in the Next-Generation Sequencing (NGS) Information & Technology Market is focused on improving accuracy and speed. Around 65% of companies are introducing advanced sequencing platforms with higher throughput. Nearly 60% of innovations include AI-based data analysis tools. About 56% of new products focus on reducing processing time and improving efficiency. Around 52% of developments aim to simplify workflows for users. Nearly 48% of manufacturers are integrating cloud-based systems for better data management. About 45% of companies are improving user interfaces to enhance accessibility. These developments are shaping the future of sequencing technologies.

Recent Developments

• Illumina Platform Upgrade: Introduced a new sequencing system improving data output by nearly 25% and reducing analysis time by around 18%, supporting faster research and diagnostics workflows.
• BGI Expansion: Expanded genomic research capabilities, increasing sequencing capacity by approximately 30% and strengthening global presence in healthcare and research sectors.
• Qiagen Innovation: Launched advanced bioinformatics tools improving data accuracy by about 20% and enhancing workflow efficiency by nearly 17% for users.
• Eurofins Scientific Development: Improved sequencing services with better automation, increasing productivity by around 22% and reducing turnaround time by nearly 15%.
• Perkinelmer Integration: Integrated AI-based analytics into sequencing platforms, improving data interpretation efficiency by approximately 19% and reducing manual processing efforts.

Report Coverage

The Next-Generation Sequencing (NGS) Information & Technology Market report provides detailed insights into market trends, growth drivers, and challenges. Around 69% of the report focuses on healthcare applications and diagnostics. Nearly 63% of the coverage highlights technological advancements and innovations in sequencing platforms. About 58% of the analysis includes regional insights and market share distribution. Around 55% of the report examines key drivers such as rising demand for genomic data and personalized medicine. Nearly 51% of the study focuses on challenges including data management and security concerns. In addition, about 48% of the coverage analyzes competitive landscape and company strategies. Around 45% of the report includes segmentation analysis by type and application, providing a clear view of market structure. This coverage helps stakeholders understand trends and identify opportunities for growth.

Next-Generation Sequencing (NGS) Information & Technology Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 7.36 Billion in 2026
Market Size Value By	USD 44.09 Billion by 2035
Growth Rate	CAGR of 19.61% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Diagnostics Oncology Drug Discovery Agriculture By Application : Targeted RNA-Seq Exome
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample

Frequently Asked Questions

• What value is the Next-Generation Sequencing (NGS) Information & Technology Market expected to touch by 2035?

  The global Next-Generation Sequencing (NGS) Information & Technology Market is expected to reach USD 44.09 Billion by 2035.

• What CAGR is the Next-Generation Sequencing (NGS) Information & Technology Market expected to exhibit by 2035?

  The Next-Generation Sequencing (NGS) Information & Technology Market is expected to exhibit a CAGR of 19.61% by 2035.

• Who are the top players in the Next-Generation Sequencing (NGS) Information & Technology Market?

  Genewiz, Macrogen, Qiagen, Novogene, Gatc Biotech, Perkinelmer, Scigenom Labs, BGI, Takara, Genotypic Technology, Dna Link, Illumina, Eurofins Scientific, Personalis

• What was the value of the Next-Generation Sequencing (NGS) Information & Technology Market in 2025?

  In 2025, the Next-Generation Sequencing (NGS) Information & Technology Market value stood at USD 7.36 Billion.